Introduction of IAVC-2024

Introduction of IAVC-2024

The 12th International Antibody and Vaccine Congress-2024 (IAVC), initiated from 2009, had been successfully organized in Beijing, Hangzhou, Nanjing, and Dalian, attracted more than 3,500 participants from 60 countries. IAVC series congresses contribute to offering professionals in the field of antibody and vaccine a multidisciplinary informative cooperative platform, and it has been the most definite and grand event in Asia. The IAVC-2024 will be held during September 12-14, 2024 in Shanghai, China.

Programmed Chapters at a Glance

Track 01: Antibody Market and Trends

Track 02: Novel Approaches to Antibody Discovery and Optimization

Track 03: Antibody Engineering and Production

Track 04: Antibody-based Diagnostics

Track 05: Antibody-drug Conjugates

Track 06: Bispecific and Multispecific Antibodies

Track 07: Biosimilars and Biosuperiors of Antibody Therapy

Track 08: Antibody-based Cancer Therapy

Track 09: Antibodies for Autoimmune Disease

Track 10: Antibodies against Infectious Disease Agents

Track 11: New Vaccines Design

Track 12: COVID-19 Vaccine

Track 13: mRNA Vaccines

Track 14: Nanoparticle Vaccine

Track 15: Cancer Vaccine

Track 16: Malaria Vaccine

Track 17: Combined Vaccines

Track 18: Vaccine Carriers and Adjuvants

Track 19: Vaccine Delivery Systems

Track 20: Vaccine Safety

Track 21: Vaccine Production and Management

Track 22: Animal Vaccines

Confirmed Distinguished Speakers

Dr. Mark Bradley, Chair and Centre Lead, Queen Mary University of London, UK	Dr. Renfeng Guo, CSO, Inflarx Pharmaceutical Inc., USA	Dr. Jens Erik Nielsen, Vice President, Enzyme Research, Novozymes A/S, Denmark
Dr. Thomas Wittlinger, Professor, Goslar Hospital, Germany	Dr. Muxiang Zhou, Professor, Emory University School of Medicine, USA	Dr. Frank Yu Wang, Professor of Chemistry, University of North Carolina, USA
Dr. Da Zhi Liu, Professor, University of California at Davis; Founder, Mirnova Therapeutics, Inc., USA	Dr. Guang Sun, Professor, Memorial University of Newfoundland, Canada	Dr. Horacio N. Pappa, Senior Director, Global Science and Standards Division, United States Pharmacopeia, USA
Dr. Franklin Wong, Professor, The University of Texas M. D. Anderson Cancer Center, USA	Dr. Michael Castagna, Chief Executive Officer, MannKind Corporation, USA	Dr. Jasmina Novakovic, Principal Scientist, Simulations Plus, Inc., USA
Dr. Bernat Kocsis, Associate Professor, Beth Israel Deaconess Medical Center, USA	Dr. Chuanxi Cai, Associate Professor, Albany Medical College, USA	Dr. Maliha Zahid, Associate Professor, Mayo Clinic, USA
Dr. Aneta Nitsch-Osuch, Professor, Medical University of Warsaw, Poland	Dr. Alexander Tuzikov, Professor, National Academy of Sciences of Belarus, Belarus	Dr. Xiaojian Yao, Director, Laboratory of Molecular Human Retrovirology, University of Manitoba, Canada
Dr. Ruola Ning, Professor, University of Rochester, USA	Dr. Maliha Zahid, Associate Professor, Mayo Clinic, USA	Dr. Zhangguo Chen, Research Associate Professor, University of Pittsburgh, USA
Dr. Keun-Hwa Lee, Professor, Hanyang University, South Korea	Dr. Chongyang Liang, Professor, School of Pharmaceutical Sciences, Jilin University, China	Dr. Jing H Wang, Associate Professor, University of Pittsburgh, USA
Dr. Haoran Yu, Principal Investigator, College of Chemical and Biological Engineering, Zhejiang University, China	Dr. Cheng Chi-Feng, Professor, Department of Oncology, Taipei City United Hospital, Taiwan	Dr. Khalid Asadi, The University of Auckland, New Zealand
Dr. Bing Li, Associate Professor, Department of Microbiology and Immunology, University of Louisville, USA	Dr. Phoency F.-H. Lai, Professor, University of Shanghai for Science and Technology, China	Dr. Oleg Kshivets, Head of Surgery Department, Bagrationovsk Hospital, Kaliningrad Oblast, Russia
Dr. Danyun Zeng, Associate Researcher, Innovation Academy for Precision Measurement Science and Technology, CAS, China	Dr. Catalin Mihalcioiu, Assistant Professor, University of Montreal Research Center (CRCHUM), Canada	Dr. Yu-Xiang Fang, Associated Investigator, Shanghai Jiao Tong University, China
Dr. Silvia Gartner, Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitari Vall d'Hebron, Spain	Dr. Xiaolei Zhu, Assistant Professor, Johns Hopkins University, USA	Dr. Rana Al Awadhi, Associate Professor, Kuwait University, Kuwait

Exhibition and Poster

IAVC-2024 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at IAVC-2024
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall

Online Registration

Earlybird Registration Now

News Released